Summary
Onconova Therapeutics Inc (Onconova) is a biopharmaceutical company that discovers and develops small molecule drug candidates for the treatment of cancer. The company’s products include dug candidates rigosertib, briciclib and recilisib. It develops drug candidates that target cancer and protects healthy cells based on its proprietary chemistry platform and cell-based differential screening. Onconova’s drug candidate rigosertib is targeted at meeting medical needs of patients with myelodysplastic syndromes (MDS). The company’s drug candidate recilisib is aimed to treat the effects of acute radiation syndromes (ARS) such as cytopenia. It partners with biopharmaceutical companies and medical organizations in the US. Onconova is headquartered in Newtown, Pennsylvania, the US.
Onconova Therapeutics Inc (ONTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Onconova Therapeutics Raises US$50 Million In Venture Financing 10
Onconova Therapeutics Raises US$26.4 Million In Venture Financing Round 11
Onconova Therapeutics Raises US$11.7 Million In Venture Financing 12
Onconova Therapeutics Raises US$19.2 Million In Series G Financing 13
Partnerships 14
GVK Biosciences Enters Into Agreement With Onconova Therapeutics To Develop New Cancer Drugs 14
Licensing Agreements 15
SymBio Pharma Amends its Licensing Agreement with Onconova Therapeutics for Rigosertib 15
Equity Offering 17
Onconova Therapeutics Raises USD17.5 Million in Rights Offering of Units 17
Onconova Therapeutics to Raise USD2 Million in Private Placement of Shares 19
Onconova Therapeutics Raises USD1.5 Million in Private Placement of Shares 21
Onconova Therapeutics Completes IPO Of Shares For US$89 Million 23
Onconova Therapeutics Inc - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Onconova Therapeutics Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Onconova Therapeutics Raises US$50 Million In Venture Financing 10
Onconova Therapeutics Raises US$26.4 Million In Venture Financing Round 11
Onconova Therapeutics Raises US$11.7 Million In Venture Financing 12
Onconova Therapeutics Raises US$19.2 Million In Series G Financing 13
GVK Biosciences Enters Into Agreement With Onconova Therapeutics To Develop New Cancer Drugs 14
SymBio Pharma Amends its Licensing Agreement with Onconova Therapeutics for Rigosertib 15
Onconova Therapeutics Raises USD17.5 Million in Rights Offering of Units 17
Onconova Therapeutics to Raise USD2 Million in Private Placement of Shares 19
Onconova Therapeutics Raises USD1.5 Million in Private Placement of Shares 21
Onconova Therapeutics Completes IPO Of Shares For US$89 Million 23
Onconova Therapeutics Inc, Key Competitors 25
Onconova Therapeutics Inc, Key Employees 26
Onconova Therapeutics Inc, Other Locations 27
List of Figures
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8